128 related articles for article (PubMed ID: 18673483)
1. DNA methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer.
Belinsky SA; Schiller JH; Stidley CA
Nutr Rev; 2008 Aug; 66 Suppl 1(Suppl 1):S24-6. PubMed ID: 18673483
[No Abstract] [Full Text] [Related]
2. Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.
Belinsky SA; Leng S; Wu G; Thomas CL; Picchi MA; Lee SJ; Aisner S; Ramalingam S; Khuri FR; Karp DD
Cancer Prev Res (Phila); 2017 Nov; 10(11):635-640. PubMed ID: 28904059
[TBL] [Abstract][Full Text] [Related]
3. [Research progress of circulating tumor DNA methylation in non-small cell lung cancer].
Yang Lan L; Chen Bojiang BJ; Li Lei L
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):967-970. PubMed ID: 30522195
[No Abstract] [Full Text] [Related]
4. Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.
Kim ES; Roy UB; Ersek JL; King J; Smith RA; Martin N; Martins R; Moore A; Silvestri GA; Jett J
J Thorac Oncol; 2019 Mar; 14(3):338-342. PubMed ID: 30709747
[No Abstract] [Full Text] [Related]
5. Newer aspects in the diagnosis, treatment, and prevention of non-small cell lung cancer. Part II.
Langer CJ; Rosvold E
Curr Probl Cancer; 1996; 20(4):217-79. PubMed ID: 8886531
[No Abstract] [Full Text] [Related]
6. [Finding mutations of interest in circulating tumor DNA helps predict immunotherapy response in lung cancer].
Guibert N; Pradines A; Favre G; Mazières J
Med Sci (Paris); 2020 May; 36(5):437-439. PubMed ID: 32452359
[No Abstract] [Full Text] [Related]
7. [Chemoprevention in non-small cell bronchial cancers].
van Zandwijk N
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S51-3. PubMed ID: 12538937
[No Abstract] [Full Text] [Related]
8. Application of a methylation gene panel by quantitative PCR for lung cancers.
Shivapurkar N; Stastny V; Suzuki M; Wistuba II; Li L; Zheng Y; Feng Z; Hol B; Prinsen C; Thunnissen FB; Gazdar AF
Cancer Lett; 2007 Mar; 247(1):56-71. PubMed ID: 16644104
[TBL] [Abstract][Full Text] [Related]
9. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
Su Y; Fang H; Jiang F
Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of genes in sputum samples as diagnostic biomarkers for non-small cell lung cancer: a meta-analysis.
Wang X; Ling L; Su H; Cheng J; Jin L
Asian Pac J Cancer Prev; 2014; 15(11):4467-74. PubMed ID: 24969871
[TBL] [Abstract][Full Text] [Related]
11. Detection of aberrant methylation of 10 genes in genomic DNA of lung tumors.
Sheikhnejad R; Zohri M; Shadmehr MB; Rahmani-Khalili M; Doozande N; Farsad Z; Sheikhzade K
Ann Oncol; 2013 Oct; 24(10):2705-2706. PubMed ID: 23956192
[No Abstract] [Full Text] [Related]
12. Biomarkers in non-small cell lung cancer prevention.
Hilbe W; Dirnhofer S; Greil R; Wöll E
Eur J Cancer Prev; 2004 Oct; 13(5):425-36. PubMed ID: 15452456
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and nonsmall cell lung cancer.
Lu F; Zhang HT
Anat Rec (Hoboken); 2011 Nov; 294(11):1787-95. PubMed ID: 21956844
[TBL] [Abstract][Full Text] [Related]
14. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation in lung cancer: biological and clinical implications.
Zöchbauer-Müller S; Minna JD; Gazdar AF
Oncologist; 2002; 7(5):451-7. PubMed ID: 12401908
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation biomarkers discovered
Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
[TBL] [Abstract][Full Text] [Related]
17. Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non-small-cell lung carcinoma.
Luo R; Song J; Xiao X; Xie Z; Zhao Z; Zhang W; Miao S; Tang Y; Ran L
Aging (Albany NY); 2020 Jul; 12(14):14649-14676. PubMed ID: 32723974
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
[TBL] [Abstract][Full Text] [Related]
19. Lung epithelial proliferation: a biomarker for chemoprevention trials?
Szabo E
J Natl Cancer Inst; 2001 Jul; 93(14):1042-3. PubMed ID: 11459858
[No Abstract] [Full Text] [Related]
20. Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer.
Suga Y; Miyajima K; Oikawa T; Maeda J; Usuda J; Kajiwara N; Ohira T; Uchida O; Tsuboi M; Hirano T; Kato H; Ikeda N
Oncol Rep; 2008 Nov; 20(5):1137-42. PubMed ID: 18949413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
